on SENSORION (EPA:ALSEN)
Sensorion to Join Key Investor Conferences in November 2024
Sensorion, a clinical-stage biotechnology company focused on hearing loss therapies, announced its participation in significant investor conferences this November. The company will attend the Stifel Healthcare Conference in New York on November 18-19, allowing for direct meetings on November 18. Concurrently, Sensorion's executives will be at the LifeSci Capital and Sofinnova Partners Summit in London on November 18.
Furthermore, Sensorion will be part of the Jefferies London Healthcare Conference from November 19-21, ensuring one-on-one interactions throughout the event. These participations aim to bolster Sensorion's presence in the investment community and further discussions on its innovative pipeline addressing hearing loss.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SENSORION news